Indaptus Therapeutics Ownership | Who Owns Indaptus Therapeutics?

Indaptus Therapeutics Ownership Summary

Indaptus Therapeutics is owned by 7.11% institutional investors, 26.67% insiders, and 66.22% retail investors. Vanguard group is the largest institutional shareholder, holding 3.04% of INDP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.25% of its assets in Indaptus Therapeutics shares.

INDP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Indaptus Therapeutics	7.11%	26.67%	66.22%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	256.26K	3.04%	$543.28K
Investment house	102.44K	1.21%	$217.17K
Geode capital management	59.31K	0.70%	$125.75K
Strategy asset managers	45.34K	0.54%	$86.59K
Pine valley investments ltd liability	44.09K	0.52%	$93.46K
Renaissance	26.60K	0.32%	$56.39K
Vivaldi capital management lp	24.00K	0.28%	$50.88K
Citadel advisors	22.21K	0.26%	$47.09K
State street	13.07K	0.15%	$27.71K
Tower research capital llc (trc)	4.10K	0.05%	$8.70K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Strategy asset managers	45.34K	0.02%	$86.59K
Vivaldi capital management lp	24.00K	0.01%	$50.88K
Investment house	102.44K	0.01%	$217.17K
Pine valley investments ltd liability	44.09K	0.01%	$93.46K
Renaissance	26.60K	0.00%	$56.39K
Beaird harris wealth management	300.00	0.00%	$636.00
Bangor savings bank	400.00	0.00%	$848.00
Tower research capital llc (trc)	4.10K	0.00%	$8.70K
Bank of america corp /de/	42.00	-	$89.00
Massmutual trust co fsb/adv	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	22.21K	-	22.21K
Geode capital management	59.31K	-	4.54K
Renaissance	26.60K	0.00%	500.00
Beaird harris wealth management	300.00	0.00%	300.00
Bank of america corp /de/	42.00	-	42.00

Top Sellers

Holder	Shares	% Assets	Change
Virtu financial	-	-	-14.23K
Ubs group	692.00	-	-1.24K
Fmr	-	-	-79.00
Pine valley investments ltd liability	44.09K	0.01%	-60.00
Wells fargo & company/mn	64.00	-	-41.00

New Positions

Holder	Shares	% Assets	Change	Value
Beaird harris wealth management	300.00	0.00%	300.00	$636.00

Sold Out

Holder	Change
Qube research	-1.00
Massmutual trust co fsb/adv	-14.00
Fmr	-79.00
Virtu financial	-14.23K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	21	23.53%	599,915	2.07%	7	14.52%	9	200.00%	3	-40.00%
Mar 31, 2024	17	-5.56%	587,768	-2.40%	6	13.61%	3	-62.50%	5	150.00%
Dec 31, 2023	18	12.50%	602,239	5.56%	7	15.54%	8	14.29%	2	-50.00%
Sep 30, 2023	16	6.67%	570,529	-2.26%	6	14.07%	7	75.00%	4	100.00%
Jun 30, 2023	15	-	583,740	0.76%	6	14.61%	4	-33.33%	2	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	229.20K	2.25%	-
Fidelity Extended Market Index	45.16K	0.44%	13.69K
Vanguard Institutional Extnd Mkt Idx Tr	27.07K	0.27%	-
Fidelity Nasdaq Composite Index	14.12K	0.14%	-
Fidelity Series Total Market Index	9.31K	0.09%	-
SSgA U.S. Extended Market Index Class I	6.40K	0.06%	-
NT Ext Equity Mkt Idx Fd - NL	6.00K	0.06%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	4.83K	0.05%	15.00
NT Ext Equity Mkt Idx Fd - L	3.59K	0.04%	-
Northern Trust Extended Eq Market Idx	3.59K	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 14, 2023	Anderson Glen R.	-	Buy	$56.01K
Aug 10, 2023	Anderson Glen R.	-	Buy	$86.05K
Aug 11, 2023	Anderson Glen R.	-	Buy	$74.34K
Nov 22, 2022	Litchev Boyan Vesselinov	Chief Medical Officer	Buy	$915.00
Dec 01, 2022	Litchev Boyan Vesselinov	Chief Medical Officer	Buy	$935.45

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	3	-

INDP Ownership FAQ

Who Owns Indaptus Therapeutics?

Indaptus Therapeutics shareholders are primarily institutional investors at 7.11%, followed by 26.67% insiders and 66.22% retail investors. The average institutional ownership in Indaptus Therapeutics's industry, Biotech Stocks , is 44.97%, which Indaptus Therapeutics falls below.

Who owns the most shares of Indaptus Therapeutics?

Indaptus Therapeutics’s largest shareholders are Vanguard group (256.26K shares, 3.04%), Investment house (102.44K shares, 1.21%), and Geode capital management (59.31K shares, 0.70%). Together, they hold 4.95% of Indaptus Therapeutics’s total shares outstanding.

Does Blackrock own Indaptus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Indaptus Therapeutics.

Who is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested?

Strategy asset managers is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 45.34K Indaptus Therapeutics shares, valued at 86.59K$.

Who is the top mutual fund holder of Indaptus Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Indaptus Therapeutics shares, with 2.25% of its total shares outstanding invested in 229.2K Indaptus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools